Suppr超能文献

脑内血管紧张素原水平低的大鼠在衰老早期不会出现胰岛素抵抗。

Rats with low brain angiotensinogen do not exhibit insulin resistance during early aging.

作者信息

Kasper Sherry O, Ferrario Carlos M, Ganten Detlev, Diz Debra I

机构信息

The Hypertension & Vascular Disease Center and Physiology/Pharmacology Department, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1032, USA.

出版信息

Endocrine. 2006 Oct;30(2):167-74. doi: 10.1385/ENDO:30:2:167.

Abstract

During aging increases in body weight, insulin resistance, and elevated systolic pressure contribute to the development of metabolic syndrome. Long-term systemic blockade of the renin-angiotensin system (RAS) with either an angiotensin (Ang) II type 1 (AT1) receptor antagonist or angiotensin converting enzyme inhibitor improves insulin sensitivity and decreases risk of new onset (type II) diabetes. However, the role of the brain RAS in mediating development of insulin insensitivity during aging is not known. Therefore, we compared responses to an oral glucose load in transgenic rats with selective antisense suppression of brain angiotensinogen (ASrAogen); (mRen2)27 rats with high brain angiotensin II; and control Hannover Sprague-Dawley (SD) rats, at wk 16 and 68 of age. ASrAogen animals had lower body weight than either SD or (mRen2)27 rats at both ages (p < 0.001). The oral glucose tolerance test at 16 wk in (mRen2)27 animals revealed a higher glucose-insulin index (154,421 +/- 11,231 units; p < 0.05) and a lower glucose-insulin index in ASrAogen rats (41,580 +/- 10,923 units, p < 0.05) compared to SD rats (97,134 +/- 19,822 units), suggesting insulin resistance in the (mRen2)27 and enhanced insulin sensitivity in the ASrAogen relative to SD rats. At 68 wk, the glucose-insulin index remained low in the ASrAogen rats as evidence of maintained insulin sensitivity during aging compared with either SD or (mRen2)27 (p < 0.05). SD animals do not differ from (mRen2)27 rats at 68 wk indicating the development of a state of relative insulin resistance with increased age in the SD rats. Moreover, there was a positive correlation (r = 0.44; p < 0.05) between body weight and the glucose-insulin index in SD, but not ASrAogen or (mRen2)27 rats. The relationships between insulin and leptin, insulin and glucose, and leptin and body weight observed in SD rats were absent in ASrAogen and (mRen2)27 rats. We conclude that the glial RAS plays a role in development of insulin resistance as well as influencing weight gain associated with early aging.

摘要

在衰老过程中,体重增加、胰岛素抵抗和收缩压升高会导致代谢综合征的发生。长期使用血管紧张素(Ang)II 1型(AT1)受体拮抗剂或血管紧张素转换酶抑制剂对肾素-血管紧张素系统(RAS)进行全身阻断,可改善胰岛素敏感性并降低新发(II型)糖尿病的风险。然而,大脑RAS在衰老过程中介导胰岛素不敏感发生发展中的作用尚不清楚。因此,我们比较了在16周龄和68周龄时,对脑内血管紧张素原选择性反义抑制的转基因大鼠(ASrAogen)、脑内血管紧张素II水平高的(mRen2)27大鼠以及对照汉诺威-斯普拉格-道利(SD)大鼠口服葡萄糖负荷的反应。在两个年龄段,ASrAogen大鼠的体重均低于SD大鼠和(mRen2)27大鼠(p<0.001)。在16周龄时,(mRen2)27大鼠的口服葡萄糖耐量试验显示,与SD大鼠(97,134±19,822单位)相比,其葡萄糖-胰岛素指数更高(154,421±11,231单位;p<0.05),而ASrAogen大鼠的葡萄糖-胰岛素指数更低(41,580±10,923单位,p<0.05),这表明(mRen2)27大鼠存在胰岛素抵抗,而ASrAogen大鼠相对于SD大鼠胰岛素敏感性增强。在68周龄时,ASrAogen大鼠的葡萄糖-胰岛素指数仍然较低,这证明与SD大鼠或(mRen2)27大鼠相比,其在衰老过程中胰岛素敏感性得以维持(p<0.05)。68周龄时,SD大鼠与(mRen2)27大鼠没有差异,这表明SD大鼠随着年龄增长出现了相对胰岛素抵抗状态。此外,SD大鼠的体重与葡萄糖-胰岛素指数之间存在正相关(r = 0.44;p<0.05),而ASrAogen大鼠和(mRen2)27大鼠则不存在这种相关性。在ASrAogen大鼠和(mRen2)27大鼠中未观察到SD大鼠中胰岛素与瘦素、胰岛素与葡萄糖以及瘦素与体重之间的关系。我们得出结论,神经胶质RAS在胰岛素抵抗的发生发展中起作用,同时也影响与早期衰老相关的体重增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验